StockData

NuCana plc (NCNA) stock

NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 1/30
$0.86−0.07 (-7.19%)

Close on Nov 16, 2026Market cap $3.59MP/E –Yield –

NuCana total assets

Total assets on the balance sheet at the end of each period.

NuCana's total assets was £25.78M at Jun 30, 2026. For fiscal 2025 it was £29.83M, up 101.9% from the year before. The highest annual figure on record is £107.79M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025£29.83M+101.9%
FY2024Dec 31, 2024£14.77M-46.9%
FY2023Dec 31, 2023£27.81M-52.3%
FY2022Dec 31, 2022£58.25M-24.8%
FY2021Dec 31, 2021£77.47M-28.1%
FY2020Dec 31, 2020£107.79M+53.4%
FY2019Dec 31, 2019£70.27M-19.4%
FY2018Dec 31, 2018£87.19M-9.5%
FY2017Dec 31, 2017£96.36M+254.1%
FY2016Dec 31, 2016£27.21M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026£25.78M+28.5%
Q4 FY2025Dec 31, 2025£29.83M+7.3%
Q2 FY2025Jun 30, 2025£16.22M-60.7%
Q4 FY2024Dec 31, 2024£14.77M-74.6%
Q2 FY2024Jun 30, 2024£20.07M-69.9%
Q4 FY2023Dec 31, 2023£27.81M-64.1%
Q2 FY2023Jun 30, 2023£41.26M-54.0%
Q4 FY2022Dec 31, 2022£58.25M-36.9%
Q2 FY2022Jun 30, 2022£66.63M-33.9%
Q4 FY2021Dec 31, 2021£77.47M-28.1%
Q3 FY2021Sep 30, 2021£89.79M-25.1%
Q2 FY2021Jun 30, 2021£92.32M+44.0%
Q1 FY2021Mar 31, 2021£100.87M+50.6%
Q4 FY2020Dec 31, 2020£107.79M+53.4%
Q3 FY2020Sep 30, 2020£119.88M+57.9%
Q2 FY2020Jun 30, 2020£64.10M-19.9%
Q1 FY2020Mar 31, 2020£67.00M-18.5%
Q4 FY2019Dec 31, 2019£70.27M-19.4%
Q3 FY2019Sep 30, 2019£75.94M-15.7%
Q2 FY2019Jun 30, 2019£79.99M-12.0%
Q1 FY2019Mar 31, 2019£82.23M-14.7%
Q4 FY2018Dec 31, 2018£87.19M+220.4%
Q3 FY2018Sep 30, 2018£90.10M–
Q2 FY2018Jun 30, 2018£90.88M–
Q4 FY2017Dec 31, 2017£96.36M–
Q4 FY2016Dec 31, 2016£27.21M–

More NuCana figures

See a number that looks wrong?